Sort
11,323 grants matching “glioblastoma”
Brain Cancer Program - 09
$2,067Stuart A Grossman · Johns Hopkins University · P30 · FY2018 · CA
EFFECTS OF PDT & GAMMA RADIATION ON HUMAN GLIOMA SPHEROIDS
$2,059Bruce J Tromberg · University Of California-Irvine · P41 · FY2010 · RR
ADVANCED CELL AND TISSUE ENGINEERING
$2,023Chung-Ho Sun · University Of California-Irvine · P41 · FY2007 · RR
Translational Therapeutics Research Program (TT)
$2,022David P Carbone · Ohio State University · P30 · FY2018 · CA
EFFECTS OF PDT & GAMMA RADIATION ON HUMAN GLIOMA SPHEROIDS
$2,021Bruce J Tromberg · University Of California-Irvine · P41 · FY2007 · RR
The Role of Sphingosine Kinases in the Growth and Invasion of Giloma Cells
$2,006Lauren E. Bryan · Virginia Commonwealth University · F31 · FY2009 · NS
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.
$1,880Tyler Eugene Miller · Cleveland Clinic Lerner Com-Cwru · F30 · FY2017 · CA
Phase 1/II Trial of CPT-11/Radiation with CPT-11 &BCNU
$1,854Mayo Clinic · M01 · FY2004 · RR
EFFECTS OF PDT & GAMMA RADIATION ON HUMAN GLIOMA SPHEROIDS
$1,828Bruce J Tromberg · University Of California-Irvine · P41 · FY2009 · RR
PERITUMORAL BRAIN EDEMA IN PATIENTS WITH PRIMARY MALIGNANT GLIOMA; (HCRF) TO DEX
$1,755Lawrence D Recht · Stanford University · M01 · FY2007 · RR
EphA2: Function and Targeting in Malignant Gliomas
$1,731Jill E Wykosky · Wake Forest University Health Sciences · F31 · FY2008 · NS
PHASE II SINGLE ARM TRIAL OF VEGF TRAP IN PATIENTS WITH RECURRENT TEMOZOLOMIDE-
$1,724Timothy Cloughesy · University Of California Los Angeles · M01 · FY2009 · RR
Immunology & Cancer Immunotherapy (ICI)
$1,665Charles L Sentman · Dartmouth College · P30 · FY2018 · CA
BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas
$1,625James D Crapo · Biomimetix Jv, Llc · R44 · FY2022 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
$1,625George Yancey Gillespie · Treovir, Inc · R44 · FY2022 · CA
Program 11: Cancer Immunology
$1,602Arlene H Sharpe · Dana-Farber Cancer Inst · P30 · FY2018 · CA
BYPASSING THE BLOOD BRAIN BARRIER: MONOCYTES AND MACROPHAGES
$1,556Henry Hirschberg · University Of California-Irvine · P41 · FY2011 · RR
CLINICAL TRIAL: PERITUMORAL BRAIN EDEMA IN PATIENTS WITH PRIMARY MALIGNANT GLIOM
$1,479Lawrence D Recht · Stanford University · M01 · FY2008 · RR
Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100
$1,450Thomas C Chen · Neonc Technologies, Inc. · R41 · FY2019 · CA
A BIOMARKER AND PHASE II STUDY OF GW 572016 IN RECURRENT MALIGNANT GLIOMA (NA
$1,426Timothy Cloughesy · University Of California Los Angeles · M01 · FY2008 · RR
Flow Cytometry
$1,367Nancy C Van Houten · Univ Of North Carolina Chapel Hill · P30 · FY2018 · CA
STUDYING EGFR INTERACTING PARTNERS
$1,304Harold E Varmus · Rockefeller University · P41 · FY2011 · RR
CLINICAL TRIAL: A PHASE 2 STUDY OF AZD2171 IN RECURRENT GLIOBLASTOMA (NCI PROTOC
$1,295Tracy T Batchelor · Massachusetts General Hospital · M01 · FY2008 · RR
LCCC 0424: PHASE I ERLOTINIB GIVEN EVERY 72 HOURS TO PATIENTS WITH GLIOBLASTOMA
$1,239Celeste M Lindley · Univ Of North Carolina Chapel Hill · M01 · FY2006 · RR
STUDYING EGFR INTERACTING PARTNERS
$1,190Harold E Varmus · Rockefeller University · P41 · FY2009 · RR